Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Intangibles (2019 - 2025)

X4 Pharmaceuticals' Intangibles history spans 3 years, with the latest figure at $9.2 million for Q4 2025.

  • For Q4 2025, Intangibles fell 7.5% year-over-year to $9.2 million; the TTM value through Dec 2025 reached $9.2 million, down 7.5%, while the annual FY2025 figure was $9.2 million, 7.5% down from the prior year.
  • Intangibles reached $9.2 million in Q4 2025 per XFOR's latest filing, down from $9.4 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $10.4 million in Q2 2024 to a low of $9.2 million in Q4 2025.